Penn Medicine Supports CARMA Therapeutics in Efforts to Develop New Oncology Treatments

CARMA Therapeutics is pleased to announce that Penn Medicine, a cellular therapy powerhouse and the cradle of the CARMA technology, has participated in a funding deal to support the Company’s  efforts to bring new groundbreaking oncology treatments to market. Penn Medicine joins a group of top tier VCs, which provided initial capital to the company.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s